165 related articles for article (PubMed ID: 19862606)
1. Rational design of multiple TB antigens TB10.4 and TB10.4-Ag85B as subunit vaccine candidates against Mycobacterium tuberculosis.
Shi S; Yu L; Sun D; Liu J; Hickey AJ
Pharm Res; 2010 Feb; 27(2):224-34. PubMed ID: 19862606
[TBL] [Abstract][Full Text] [Related]
2. Exchanging ESAT6 with TB10.4 in an Ag85B fusion molecule-based tuberculosis subunit vaccine: efficient protection and ESAT6-based sensitive monitoring of vaccine efficacy.
Dietrich J; Aagaard C; Leah R; Olsen AW; Stryhn A; Doherty TM; Andersen P
J Immunol; 2005 May; 174(10):6332-9. PubMed ID: 15879133
[TBL] [Abstract][Full Text] [Related]
3. Performance of Homologous and Heterologous Prime-Boost Immunization Regimens of Recombinant Adenovirus and Modified Vaccinia Virus Ankara Expressing an Ag85B-TB10.4 Fusion Protein against
Kou Y; Wan M; Shi W; Liu J; Zhao Z; Xu Y; Wei W; Sun B; Gao F; Cai L; Jiang C
J Microbiol Biotechnol; 2018 Jun; 28(6):1022-1029. PubMed ID: 29847865
[TBL] [Abstract][Full Text] [Related]
4. Immunogenicity and protective efficacy of a fusion protein vaccine consisting of antigen Ag85B and HspX against Mycobacterium tuberculosis infection in mice.
Li Q; Yu H; Zhang Y; Wang B; Jiang W; Da Z; Xian Q; Wang Y; Liu X; Zhu B
Scand J Immunol; 2011 Jun; 73(6):568-76. PubMed ID: 21323695
[TBL] [Abstract][Full Text] [Related]
5. Alteration of epitope recognition pattern in Ag85B and ESAT-6 has a profound influence on vaccine-induced protection against Mycobacterium tuberculosis.
Bennekov T; Dietrich J; Rosenkrands I; Stryhn A; Doherty TM; Andersen P
Eur J Immunol; 2006 Dec; 36(12):3346-55. PubMed ID: 17109467
[TBL] [Abstract][Full Text] [Related]
6. Assessment of the genetic diversity of Mycobacterium tuberculosis esxA, esxH, and fbpB genes among clinical isolates and its implication for the future immunization by new tuberculosis subunit vaccines Ag85B-ESAT-6 and Ag85B-TB10.4.
Davila J; Zhang L; Marrs CF; Durmaz R; Yang Z
J Biomed Biotechnol; 2010; 2010():208371. PubMed ID: 20617139
[TBL] [Abstract][Full Text] [Related]
7. Protection and polyfunctional T cells induced by Ag85B-TB10.4/IC31 against Mycobacterium tuberculosis is highly dependent on the antigen dose.
Aagaard C; Hoang TT; Izzo A; Billeskov R; Troudt J; Arnett K; Keyser A; Elvang T; Andersen P; Dietrich J
PLoS One; 2009 Jun; 4(6):e5930. PubMed ID: 19529771
[TBL] [Abstract][Full Text] [Related]
8. [Preparation of TAT-Ag85B protein vaccine and evaluation of its anti-Myobacterium tuberculosis effect].
Zhang R; Wang W; Hu D; Wang W; Xing Y; He J; Dai J; Wu J
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2015 Jan; 31(1):49-53. PubMed ID: 25575059
[TBL] [Abstract][Full Text] [Related]
9. Gene-based neonatal immune priming potentiates a mucosal adenoviral vaccine encoding mycobacterial Ag85B.
Dai G; Rady HF; Huang W; Shellito JE; Mason C; Ramsay AJ
Vaccine; 2016 Dec; 34(50):6267-6275. PubMed ID: 27823900
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant bacille Calmette-Guérin vaccine secreting interleukin-15/antigen 85B fusion protein in providing protection against Mycobacterium tuberculosis.
Tang C; Yamada H; Shibata K; Maeda N; Yoshida S; Wajjwalku W; Ohara N; Yamada T; Kinoshita T; Yoshikai Y
J Infect Dis; 2008 May; 197(9):1263-74. PubMed ID: 18422438
[TBL] [Abstract][Full Text] [Related]
11. A recombinant adenovirus expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis elicits strong antigen-specific immune responses in mice.
Li W; Deng G; Li M; Zeng J; Zhao L; Liu X; Wang Y
Mol Immunol; 2014 Nov; 62(1):86-95. PubMed ID: 24980867
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the predicted population coverage of tuberculosis vaccine candidates Ag85B-ESAT-6, Ag85B-TB10.4, and Mtb72f via a bioinformatics approach.
Davila J; McNamara LA; Yang Z
PLoS One; 2012; 7(7):e40882. PubMed ID: 22815851
[TBL] [Abstract][Full Text] [Related]
13. The LTK63 adjuvant improves protection conferred by Ag85B DNA-protein prime-boosting vaccination against Mycobacterium tuberculosis infection by dampening IFN-gamma response.
Palma C; Iona E; Giannoni F; Pardini M; Brunori L; Fattorini L; Del Giudice G; Cassone A
Vaccine; 2008 Aug; 26(33):4237-43. PubMed ID: 18584925
[TBL] [Abstract][Full Text] [Related]
14. Recombinant Ag85B vaccine by taking advantage of characteristics of human parainfluenza type 2 virus vector showed Mycobacteria-specific immune responses by intranasal immunization.
Watanabe K; Matsubara A; Kawano M; Mizuno S; Okamura T; Tsujimura Y; Inada H; Nosaka T; Matsuo K; Yasutomi Y
Vaccine; 2014 Mar; 32(15):1727-35. PubMed ID: 24486310
[TBL] [Abstract][Full Text] [Related]
15. Protection of macaques against Mycobacterium tuberculosis infection by a subunit vaccine based on a fusion protein of antigen 85B and ESAT-6.
Langermans JA; Doherty TM; Vervenne RA; van der Laan T; Lyashchenko K; Greenwald R; Agger EM; Aagaard C; Weiler H; van Soolingen D; Dalemans W; Thomas AW; Andersen P
Vaccine; 2005 Apr; 23(21):2740-50. PubMed ID: 15780721
[TBL] [Abstract][Full Text] [Related]
16. Recombinant bacille Calmette-Guerin coexpressing Ag85b, CFP10, and interleukin-12 elicits effective protection against Mycobacterium tuberculosis.
Chen YY; Lin CW; Huang WF; Chang JR; Su IJ; Hsu CH; Cheng HY; Hsu SC; Dou HY
J Microbiol Immunol Infect; 2017 Feb; 50(1):90-96. PubMed ID: 25732698
[TBL] [Abstract][Full Text] [Related]
17. Chimaeric protein improved immunogenicity compared with fusion protein of Ag85B and ESAT-6 antigens of Mycobacterium tuberculosis.
Xu Y; Wang B; Chen J; Wang Q; Zhu B; Shen H; Qie Y; Wang J; Wang H
Scand J Immunol; 2006 Nov; 64(5):476-81. PubMed ID: 17032239
[TBL] [Abstract][Full Text] [Related]
18. Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis.
D'Souza S; Rosseels V; Romano M; Tanghe A; Denis O; Jurion F; Castiglione N; Vanonckelen A; Palfliet K; Huygen K
Infect Immun; 2003 Jan; 71(1):483-93. PubMed ID: 12496199
[TBL] [Abstract][Full Text] [Related]
19. Monitoring antigenic protein integrity during glycoconjugate vaccine synthesis using capillary electrophoresis-mass spectrometry.
Tengattini S; Domínguez-Vega E; Temporini C; Terreni M; Somsen GW
Anal Bioanal Chem; 2016 Sep; 408(22):6123-32. PubMed ID: 27372716
[TBL] [Abstract][Full Text] [Related]
20. Optimizing Escherichia coli as a protein expression platform to produce Mycobacterium tuberculosis immunogenic proteins.
Piubelli L; Campa M; Temporini C; Binda E; Mangione F; Amicosante M; Terreni M; Marinelli F; Pollegioni L
Microb Cell Fact; 2013 Nov; 12():115. PubMed ID: 24252280
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
